Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-21-031435)

Filing Details

Accession Number:: 0001209191-21-031435
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-05-10 13:00:00
Reporting Period:: 2021-05-07

Accepted Time:: 2021-05-10 19:48:47
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1340652	Chemocentryx Inc.	CCXI	Pharmaceutical Preparations (2834)	943254365

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1845266	Tausif Butt	C/O Chemocentryx, Inc. 850 Maude Avenue Mountain View CA 94043	Evp, Chief Operating Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-05-07	10,870	$11.06	10,870	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Reflects the weighted average sale price of the shares purchased. The shares were purchased in multiple trades at prices ranging from $11.02 to $11.12 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.